Informed Choice - Compass
Megadott ok: Business decision to terminate the study early. Primary endpoint will not be assessed.
Key facts
- Where
- Annapolis, Aurora, Brooklyn, Charleston, Charlotte, Chicago, Columbia, Columbus, Harrisburg, Houston, Jackson, Jacksonville, Jersey City, La Vista, Los Angeles, Marietta, Miami, New Orleans, Niagara Falls, Oklahoma City, Panama City, Pharr, Philadelphia, Phoenix, Pleasant View, Port Hueneme, Pottstown, Providence, Rockville, Rosedale, Roy, Saginaw, South Ogden, Spring, St Louis, Sugarland, Suwanee és Union City, Egyesült ÁllamokSee the 39 sites
Where in Egyesült Államok
- Annapolis Internal MedicineAnnapolis, Egyesült ÁllamokNo longer taking part
- Skylight Health GroupAurora, Egyesült ÁllamokNo longer taking part
- Ellipsis Research Group, LLCBrooklyn, Egyesült ÁllamokNo longer taking part
- Medical University of South CarolinaCharleston, Egyesült ÁllamokNo longer taking part
- Onsite Clinical Solutions, LLCCharlotte, Egyesült ÁllamokNo longer taking part
- Sheridan Medical Center, S.CChicago, Egyesült ÁllamokNo longer taking part
- SPICA Clinical ResearchColumbia, Egyesült ÁllamokNo longer taking part
- ClinCept, LLCColumbus, Egyesült ÁllamokNo longer taking part
- Skylight HealthHarrisburg, Egyesült ÁllamokNo longer taking part
- Clear Brook Medical AssociatesHouston, Egyesült ÁllamokNo longer taking part
- The Jackson Clinic, PAJackson, Egyesült ÁllamokNo longer taking part
- Skylight Health GroupJacksonville, Egyesült ÁllamokNo longer taking part
- Alliance Community Healthcare, INCJersey City, Egyesült ÁllamokNo longer taking part
- Barrett ClinicLa Vista, Egyesült ÁllamokNo longer taking part
- Biopharma InformaticLos Angeles, Egyesült ÁllamokNo longer taking part
- Pivotal Clinical Research & Associates, LLCMarietta, Egyesült ÁllamokNo longer taking part
- I.V.A.M Clinical & Investigational CenterMiami, Egyesült ÁllamokNo longer taking part
- ITB ResearchMiami, Egyesült ÁllamokNo longer taking part
- Ascension DePaul Community Services of New OrleansNew Orleans, Egyesült ÁllamokNo longer taking part
- Niagara Falls Memorial Medical CenterNiagara Falls, Egyesült ÁllamokNo longer taking part
- Hightower Clinical OKCOklahoma City, Egyesült ÁllamokNo longer taking part
- Emerald Coast OBGYNPanama City, Egyesült ÁllamokNo longer taking part
- BioPharma InformaticPharr, Egyesült ÁllamokNo longer taking part
- Mercado Medical PracticePhiladelphia, Egyesült ÁllamokNo longer taking part
- Absolute Clinical ResearchPhoenix, Egyesült ÁllamokNo longer taking part
- Ogden Clinic - Mountain ViewPleasant View, Egyesült ÁllamokNo longer taking part
- Saviers Medical GroupPort Hueneme, Egyesült ÁllamokNo longer taking part
- Pottstown Medical Specialists IncPottstown, Egyesült ÁllamokNo longer taking part
- Center for Medical Research, LLCProvidence, Egyesült ÁllamokNo longer taking part
- Advanced Primary and Geriatric CareRockville, Egyesült ÁllamokNo longer taking part
- Laurelton Heart Specialist, PCRosedale, Egyesült ÁllamokNo longer taking part
- Ogden Clinic Grand ViewRoy, Egyesült ÁllamokNo longer taking part
- Valley OB-GYN Clinic, PCSaginaw, Egyesült ÁllamokNo longer taking part
- South Ogden Family MedicineSouth Ogden, Egyesült ÁllamokNo longer taking part
- Valena Medical ResearchSpring, Egyesült ÁllamokNo longer taking part
- St. Louis Medical ProfessionalsSt Louis, Egyesült ÁllamokNo longer taking part
- A & U Family MedicineSugarland, Egyesült ÁllamokNo longer taking part
- Herman Clinical Research LLCSuwanee, Egyesült ÁllamokNo longer taking part
- North Hudson Community Action CorporationUnion City, Egyesült ÁllamokNo longer taking part
Trial details
- Who runs it
- Exact Sciences Corporation
- Trial code
- NCT05246839
- Record updated
- 2025. november 10.
- Original description
The primary objective of this study is to evaluate the impact of a theoretically grounded video that includes information about CRC screening modality choices on CRC screening rates and time adherent to CRC guidelines. The results will not be posted because the study terminated early and the primary endpoint was not analyzed.Read full original descriptionShow less
Informed Choice Intervention for Colorectal Cancer Screening: Compass
The primary objective of this study is to evaluate the impact of a theoretically grounded video that includes information about CRC screening modality choices on CRC screening rates and time adherent to CRC guidelines. The results will not be posted because the study terminated early and the primary endpoint was not analyzed.
Inclusion: Participant is 45 to 70 years of age, inclusive; Participant presents for a primary care appointment; Participant understands the study procedures and can provide informed consent to participate in the study and authorization for release of relevant protected health information (PHI) to the study Investigator; Participant has never been screened for CRC.
Exclusion: Participant has a family history of CRC in at least one first- or second-degree relative diagnosed prior to age 60 and/or at least 2 first-degree relatives diagnosed with CRC at any age; Participant is current with CRC screening, including gFOBT or FIT within the preceding 12 months, Cologuard within the preceding 3 years, flexible sigmoidoscopy or CT colonography within the preceding 5 years, or colonoscopy within the preceding 10 years. Participants can be enrolled up to 3 months prior to screening due date; Participant has a personal history of CRC or colonic adenomatous or sessile serrated polyps; Participant has a personal history of inflammatory bowel disease; Participant has a personal diagnosis or family history of any of the following conditions:; Familial adenomatous polyposis (also referred to as "FAP", including attenuated FAP and Gardner's syndrome),; Hereditary non-polyposis CRC syndrome (also referred to as "HNPCC" or "Lynch Syndrome"),; Other hereditary cancer syndromes including, but are not limited to Peutz-Jeghers Syndrome, MYH-Associated Polyposis (MAP), Turcot's (or Crail's) Syndrome, Cowden's Syndrome, Juvenile Polyposis, Neurofibromatosis, or Familial Hyperplastic Polyposis; Participant has a diagnosis of Cronkhite-Canada Syndrome; Participant has any condition that in the opinion of the Investigators should preclude participation in the study, including comorbid illnesses precluding endoscopic evaluation or that limit life expectancy to less than 10 years; Participant has symptoms or signs that require immediate, or near-term referral for diagnostic or therapeutic colonoscopy; Participant is due for CRC screening within three months and is already scheduled for colonoscopy.